Reuters logo
BRIEF-Ampio announces accepted publication of pooled Ampion™ clinical trial results
October 12, 2017 / 1:34 PM / 8 days ago

BRIEF-Ampio announces accepted publication of pooled Ampion™ clinical trial results

Oct 12 (Reuters) - Ampio Pharmaceuticals Inc:

* Ampio announces accepted publication of pooled Ampion™ clinical trial results in patients with severe osteoarthritis of the knee

* Ampio Pharmaceuticals Inc - ‍Ampion is in late-stage development to treat signs and symptoms of severe oak​

* Ampio - ‍based on FDA guidance, co recently completed enrollment in 12-week pivotal trial of Ampion, enrolled patients with severe oak (KL grade 4)​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below